Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Apple Mobile Web Clips Icon

Google Font API

Content Delivery Network

WordPress

Font Awesome

LetsEncrypt

Finance and Administration

Dan Teichmann

Business Management

Aaron Royston

Corey Goodman

Managing Partner

Richard Gaster

Yvonne Yamanaka

Founding Partner

Robert Adelman

Behzad Aghazadeh

Managing Team

Partner

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Venture Stage Investors with Investments in Brooklyn, New York

Early Stage Venture Investors with Investments in Texas

Investors Active in Asia-Pacific (APAC) (Top 10K)

Venture Capital Investors (Top 10K)

VenBio invests in promising companies at various stages: from early to late stages, and from academic startups to spinouts. It tends to lead most of its investments, and it enjoys building syndicates and teams.

The company is mindful of potential acquisition partners from the outset, and it ensures that its companies are best positioned to meet their requirements. This includes IP, CMC, and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Its team’s expertise and involvement help companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that they work with.

venBio Fund V

venBio Global Strategic Fund IV

venBio Global Strategic Fund III

venBio Global Strategic Fund II

San Francisco

California

United States

North America

venBio Partners

Axonis Therapeutics: $115 Million (Series A) Raised To Develop Novel Neuromedicines

Axonis Therapeutics bags $115m for neuromedicine development

Axonis Therapeutics Raises $115M in Series A Financing

Axonis Therapeutics Announces $115 Million Series A Financing

The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme

The Week’s 10 Biggest Funding Rounds: Another Big Week For Biotech And AI

Hong Kong

Asia

Palestinian Territory

BioAdvance is a Pennsylvania-based venture capital firm that provides funding for life sciences and biotechnology companies.

BioAdvance

Shield Capital is a venture capital firm that invests in various industries, including life sciences and biotechnology.

Shield Capital

R/GA Ventures is a global innovation firm that invests in startups across various sectors, including life sciences and biotechnology.

R/GA Ventures

Avoro Capital Advisors is a global firm focused on funding and investments in biotechnology, life sciences, and specialty therapeutics.

Avoro Capital Advisors

Venbio is a life sciences investment firm that specializes in building and investing in innovative healthcare companies. The firm focuses on creating and funding companies that address unmet medical needs with novel therapeutic products.

Venbio

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 6:13 AM	08ad106c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:09 AM	077cb2b0
crunchbase profile	general	Nov 25, 2024 9:48 AM	ee60e892
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 4:24 PM	c63c240f
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

VENB

COM:VENBIO

Venbio